Your session is about to expire
← Back to Search
Pre-op Cognitive Behavior Therapy for Post-Surgical Pain
N/A
Waitlist Available
Led By Peggy Compton, RN, PhD, FAAN
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 hours post-operatively; 3-months; 6-months
Awards & highlights
Summary
This trial tests a computer-assisted behavior intervention that uses motivational interviewing to address risk factors for CPSP before knee surgery. It is expected that this will reduce the severity of post-op pain and the incidence of CPSP.
Eligible Conditions
- Chronic Postsurgical Pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 48 hours post-operatively; 3-months; 6-months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48 hours post-operatively; 3-months; 6-months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Preoperative Chronic Pain Severity
Secondary outcome measures
Chronic Post-Surgical Pain
Post-Op Anxiety
Post-Op Depression
+7 moreTrial Design
2Treatment groups
Active Control
Group I: Treatment-as-usual (control)Active Control1 Intervention
Patients scheduled to undergo total joint arthroplasty at the study site are automatically enrolled in a mandatory 4-hour education class delivered by a nurse educator or physical therapist. Utilizing an in-person Powerpoint presentation format, patients are informed about pre-habilitation exercises to do prior to surgery; what to expect the day of surgery; the multimodal analgesia protocol used in the perioperative period; options for anesthesia and analgesia; and the expectation of physical therapy after surgery.
Group II: Computer-Assisted Preoperative CBT InterventionActive Control1 Intervention
Patients will receive the computer-assisted preoperative CBT intervention (n=75). A particularly promising internet-based CBT pain program for the population of interest, PAINTrainer, demonstrated improved pain, function, coping and global health in patients with chronic knee arthritic pain in comparison to an internet education control, with benefits persisting for up to 52 weeks. In addition to the PAINTrainer, there will be an integration of a motivational interviewing (MI) intervention delivered by a trained "coach" across the sessions about (1) the benefits of opioid tapering for post-operative pain control, (2) approaches for safely tapering, (3) identifying and managing withdrawal symptoms patients may experience.
Find a Location
Who is running the clinical trial?
University of PennsylvaniaLead Sponsor
2,027 Previous Clinical Trials
42,885,657 Total Patients Enrolled
Peggy Compton, RN, PhD, FAANPrincipal Investigator - University of Pennsylvania
University of Pennsylvania
Martin D Cheatle, PhDPrincipal InvestigatorUniversity of Pennsylvania
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have been taking a strong pain medication like morphine for a long time.You have pain caused by cancer.You have a current or past history of opioid addiction, even if you are using medication to help with the addiction.Previous knee replacement surgery.You have had ongoing, non-cancer-related pain for at least 3 months.You are older than 21 years old, whether you are male or female.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment-as-usual (control)
- Group 2: Computer-Assisted Preoperative CBT Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger